Translate ideas into impact
Explore current openings and get ready to prove that impossible isn’t.Unlimit with us
On Thursday, July 22, 2021, Absci debuted on Wall Street with an IPO, raising about $200 million in the name of further developing our AI-powered Integrated Drug Creation Platform™ to identify biologics and help speed the development of new treatments.
Our public debut generated buzz among both the business and life sciences communities. For more information, check out the list of the top ten news articles covering the IPO: